Effects of N-3 fatty acids (DHA and EPA) on cognitive control and associated brain activity in ADHD: A double-blind placebo controlled study

Completed

• Conditions: ADHD; attention deficit; 10012562

• Registration Number: NL-OMON35299
• Lead Sponsor: nilever

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

General:
1) 8-14 year old boys
2) Used to daily consumption of margarine
3) Sufficient mastery of the Dutch language of both the subject and his parents
ADHD-group:
1)DSM-IV (APA, 1994) diagnosis of ADHD, according to DISC interview
2) Scores in the clinical range on the Child Behaviour Checklist (CBCL) and Teacher Rating Form(TRF)

Exclusion Criteria

1) mental retardation (IQ < 70)
2) major illness of the cardiovascular, the endocrine, the pulmonary or the gastrointestinal system
3) presence of metal objects in or around the body (pacemaker, dental braces)
4) history of or present neurological disorder
5) regular use of n-3 or n-6 fatty acid dietary supplements, products fortified with EPA or DHA, a regular diet high in fatty fish in the four months prior to study participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified